Imaging of T cells expressing chimeric antigen receptors

Immunotherapy

Volumn 3, Issue 12, 2011, Pages 1411-1414

  Roszik, Janos ^a   Rabinovich, Brian ^a   Cooper, Laurence Jn ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

chimeric antigen receptor; imaging; macroscopic; microscopic; T cells

Indexed keywords

CHIMERIC ANTIGEN RECEPTOR; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; BIOLUMINESCENCE; CELL MIGRATION; COMPUTER ASSISTED TOMOGRAPHY; DNA MODIFICATION; FLUORESCENCE MICROSCOPY; HUMAN; LYMPHOCYTE FUNCTION; MOLECULAR IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; T LYMPHOCYTE; TUMOR CELL;

ANIMALS; CELL MOVEMENT; HUMANS; IMMUNOTHERAPY, ADOPTIVE; RECEPTORS, ANTIGEN, T-CELL; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES; TIME-LAPSE IMAGING;

EID: 81855217335     PISSN: 1750743X     EISSN: 17507448     Source Type: Journal    
DOI: 10.2217/imt.11.138     Document Type: Review

References (25)

1. Kohn DB, Dotti G, Brentjens R et al. CARs on track in the clinic. Mol. Ther. 19(3), 432-438 (2011).
2. Kochenderfer JN, Wilson WH, Janik JE et al. Eradication of B lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19. Blood 116(20), 4099-4102 (2010).
3. Porter DL, Levine BL, Kalos M, Bagg A, June CH. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N. Engl. J. Med. 365(8), 725-733 (2011).
4. Kalos M, Levine BL, Porter Dl et al. T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Sci. Transl. Med. 3(95), 95ra73 (2011).
5. Pule MA, Savoldo B, Myers GD et al. Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma. Nat. Med. 14(11), 1264-1270 (2008).
6. Singh H, Najjar AM, Olivares S et al. PET imaging of T cells derived from umbilical cord blood. Leukemia 23(3), 620-622 (2009).
7. Rabinovich BA, Ye Y, Etto T et al. Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer. Proc. Natl Acad. Sci.
8. Loening AM, Wu AM, Gambhir SS. Red-shifted Renilla reniformis luciferase variants for imaging in living subjects. Nat. Methods 4(8), 641-643 (2007).
9. Santos EB, Yeh R, Lee J et al. Sensitive in vivo imaging of T cells using a membrane-bound Gaussia princeps luciferase. Nat. Med. 15(3), 338-344 (2009).
10. Singh H, Serrano LM, Pfeiffer T et al. Combining adoptive cellular and immunocytokine therapies to improve treatment of B lineage malignancy. Cancer Res. 67(6), 2872-2880 (2007).
11. Soghomonyan S, Hajitou A, Rangel R et al. Molecular PET imaging of HSV1-tk reporter gene expression using [18F]FEAU. Nat. Protoc. 2(2), 416-423 (2007).
12. + cells in experimental myocardial infarction: long-term survival, sustained functional improvement, and mechanism of action. Circ. Res. 106(12), 1904-1911 (2010).
13. Yaghoubi SS, Couto MA, Chen CC et al. Preclinical safety evaluation of 18F-FHBG: a PET reporter probe for imaging herpes simplex virus type 1 thymidine kinase (HSV1-tk) or mutant HSV1-sr39tk's expression. J. Nucl. Med. 47(4), 706-715 (2006).
14. Pittet MJ, Grimm J, Berger CR et al. In vivo imaging of T cell delivery to tumors after adoptive transfer therapy. Proc. Natl Acad. Sci.
15. Parente-Pereira AC, Burnet J, Ellison D et al. Trafficking of CAR-engineered human t cells following regional or systemic adoptive transfer in SCID beige mice. J. Clin. Immunol. 31(4), 710-718 (2011).
16. Meier R, Golovko D, Tavri S et al. Depicting adoptive immunotherapy for prostate cancer in an animal model with magnetic resonance imaging. Magn. Reson. Med. 65(3), 756-763 (2011).
17. Serrano LM, Pfeiffer T, Olivares S et al. Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy. Blood 107(7), 2643-2652 (2006).
18. + T cell concentration determines their efficiency in killing cognate antigen-expressing syngeneic mammalian cells in vitro and in mouse tissues. J. Exp. Med. 207(1), 223-235 (2010).
19. Roszik J, Sebestyen Z, Govers C et al. T cell synapse formation depends on antigen recognition but not CD3 interaction: studies with TCR:z, a candidate transgene for TCR gene therapy. Eur. J. Immunol. 41(5), 1288-1297 (2011).
20. Stephan MT, Ponomarev V, Brentjens RJ et al. T cell-encoded CD80 and 4 1BBL induce auto- and transcostimulation, resulting in potent tumor rejection. Nat. Med. 13(12), 1440-1449 (2007).
21. Lindstrom S, Andersson-Svahn H. Miniaturization of biological assays - overview on microwell devices for single-cell analyses. Biochim. Biophys. Acta 1810(3), 308-316 (2011).
22. Zal T, Chodaczek G. Intravital imaging of anti-tumor immune response and the tumor microenvironment. Semin. Immunopathol. 32(3), 305-317 (2010).
23. Liu Z, Kim JH, Falo LD Jr, You Z. Tumor regulatory T cells potently abrogate antitumor immunity. J. Immunol. 182(10), 6160-6167 (2009).
24. Livet J, Weissman TA, Kang H et al. Transgenic strategies for combinatorial expression of fluorescent proteins in the nervous system. Nature 450(7166), 56-62 (2007).
25. Larabell CA, Nugent KA. Imaging cellular architecture with x rays. Curr. Opin Struct. Biol. 20(5), 623-631 (2010).